Acutus Medical, Inc.: Nasdaq/NYSE listing notice — Acutus Medical transfers to Nasdaq Capital Market; bid price compliance extended to April 2024

Acutus Medical, Inc.

Approved transfer from Nasdaq Global Market to The Nasdaq Capital Market effective Oct 31, 2023; symbol remains "AFIB".
Granted additional 180-day compliance period until April 29, 2024 to regain $1.00 minimum bid price.
If non-compliant after extended period, Nasdaq may initiate delisting; Company can appeal.
Company may consider a reverse stock split to cure the bid price deficiency.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Acutus Medical, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: minimum bid price
Rules: 5810(c)(3)(A)

Exact text from the filing

ymbol “AFIB”. The Nasdaq Capital Market is a continuous trading market that operates in substantially the same manner as The Nasdaq Global Market and listed companies must meet certain financial requirements and comply with Nasdaq’s corporate governance requirements. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), if a company listed on The Nasdaq Capital Market is not deemed in compliance before the expiration of the 180-day compliance period, it will be afforded an additional 180-day compliance period, provided that on the 180th day of the first compliance period it meets the applicable marke

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001628280-23-035584

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.